Vifor Fresenius Medical Care Renal Pharma Ltd.

10% owner at ChemoCentryx, Inc.

Sold, on record
$188M
Dollars the filings state
Form 4 sales
4
Latest Oct 12, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ChemoCentryx, Inc.Plan not stated
    Jul 13, 2020 2020

    Sold 245,844 shares at $59.20 ($14.6M)

    Vifor Fresenius Medical Care Renal Pharma Ltd., 10% owner

    Sold 2.4% of holdings ($611M position)10.1M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ChemoCentryx, Inc.Plan not stated
    Jul 24, 2020 +11 days

    Sold 133,074 shares at $54.61 ($7.3M)

    Vifor Fresenius Medical Care Renal Pharma Ltd., 10% owner

    Sold 1.4% of holdings ($526M position)9.5M shares leftFiling

  3. 3 Form 4 sale ChemoCentryx, Inc.Plan not stated
    Jul 29, 2020 +5 days

    Sold 162,408 shares at $52.97 ($8.6M)

    Vifor Fresenius Medical Care Renal Pharma Ltd., 10% owner

    Sold 1.7% of holdings ($503M position)9.3M shares leftFiling

  4. 4 Form 4 sale ChemoCentryx, Inc.Unusual
    Oct 12, 2021 +440 days

    Sold 4M shares at $39.43 ($158M)

    Vifor Fresenius Medical Care Renal Pharma Ltd., 10% owner

    Sold 43.5% of holdings ($363M position)5.2M shares left24.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Vifor Fresenius Medical Care Renal Pharma Ltd.
Source
Oct 12, 2021Oct 13, 2021ChemoCentryx, Inc.10% ownerForm 4 sale4M$158M43.5%UnusualSEC
Jul 29, 2020Jul 29, 2020ChemoCentryx, Inc.10% ownerForm 4 sale162,408$8.6M1.7%Plan not statedSEC
Jul 24, 2020Jul 24, 2020ChemoCentryx, Inc.10% ownerForm 4 sale133,074$7.3M1.4%Plan not statedSEC
Jul 13, 2020Jul 13, 2020ChemoCentryx, Inc.10% ownerForm 4 sale245,844$14.6M2.4%Plan not statedSEC